Fludarabine Phosphate (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Teva Parenteral Medicines, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
NON-PROPRIETARY NAME: | Fludarabine Phosphate |
SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2003-09-12 |
END MARKETING DATE: | 2018-12-31 |
Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Fludarabine Phosphate from Teva Parenteral Medicines, Inc. |
LABELER NAME: | Teva Parenteral Medicines, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/2mL) |
START MARKETING DATE: | 2003-09-12 |
END MARKETING DATE: | 2018-12-31 |
PRODUCT ID: | 0703-5854_e138bb88-2459-440d-ac50-fbb561c4b4b3 |
PRODUCT NDC: | 0703-5854 |
APPLICATION NUMBER: | ANDA076349 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers: